Total Holdings
66
Portfolio diversification across 66 positions
JDOC
(NASDAQ)JPMorgan Healthcare Leaders ETF
$59.30-- (--)
Loading... - Market loading
JDOC ETF Holdings: JPMorgan Healthcare Leaders ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$8.87M
Total fund assets
Expense Ratio
0.65%
Annual management fee
Fund Issuer
JPMorgan Chase
NASDAQ
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Johnson & Johnson | Stock | 8.59% |
| 2 |  | Eli Lilly and Company | Stock | 7.46% |
| 3 |  | AbbVie Inc. | Stock | 5.63% |
| 4 |  | Merck & Co., Inc. | Stock | 5.03% |
| 5 | L LON:AZN | AstraZeneca PLC | Stock | 4.86% |
| 6 | L LSE:AZN | AstraZeneca PLC | Stock | 4.75% |
| 7 |  | Danaher Corporation | Stock | 3.36% |
| 8 |  | UnitedHealth Group Incorporated | Stock | 3.30% |
| 9 |  | Medtronic plc | Stock | 3.13% |
| 10 | S SWX:ROG | Roche Holding AG | Stock | 2.98% |
| 11 | L LSE:0QIU | Novo Nordisk A/S Class B | Stock | 2.92% |
| 12 | C CPH:NOVO.B | Novo Nordisk A/S | Stock | 2.70% |
| 13 |  | CVS Health Corporation | Stock | 2.67% |
| 14 |  | Bristol-Myers Squibb Company | Stock | 2.66% |
| 15 |  | McKesson Corporation | Stock | 2.44% |
| 16 | E EBR:ARGX | Argen-X | Stock | 2.43% |
| 17 |  | Boston Scientific Corporation | Stock | 2.24% |
| 18 |  | Regeneron Pharmaceuticals, Inc. | Stock | 2.18% |
| 19 | E EPA:EL | EssilorLuxottica Société anonyme | Stock | 2.13% |
| 20 |  | Edwards Lifesciences Corporation | Stock | 1.97% |
| 21 | T TYO:7741 | HOYA Corporation | Stock | 1.97% |
| 22 | E EBR:UCB | UCB SA | Stock | 1.97% |
| 23 | S SWX:LONN | Lonza Group AG | Stock | 1.91% |
| 24 |  | Vertex Pharmaceuticals Incorporated | Stock | 1.82% |
| 25 | T TSE:7741 | Hoya Cor | Stock | 1.80% |
| 26 |  | Cardinal Health, Inc. | Stock | 1.78% |
| 27 |  | Stryker Corporation | Stock | 1.69% |
| 28 |  | Thermo Fisher Scientific Inc | Stock | 1.69% |
| 29 |  | Intuitive Surgical, Inc | Stock | 1.51% |
| 30 |  | IQVIA Holdings Inc | Stock | 1.40% |
| 31 | E ETR:FRE | Fresenius SE & Co. KGaA | Stock | 1.21% |
| 32 | T TA:TEVA | Teva Pharmaceutical Industries Ltd | Stock | 1.11% |
| 33 | E ETR:SRT3 | Sartorius Aktiengesellschaft | Stock | 1.07% |
| 34 | S SWX:NOVN | Novartis AG | Stock | 1.05% |
| 35 |  | Apogee Therapeutics, Inc. Common Stock | Stock | 0.97% |
| 36 | T TSE:4568 | Daiichi Sankyo Co. Ltd. | Stock | 0.94% |
| 37 |  | Biogen Inc | Stock | 0.92% |
| 38 |  | Neurocrine Biosciences, Inc | Stock | 0.86% |
| 39 |  | Ionis Pharmaceuticals, Inc | Stock | 0.81% |
| 40 |  | Disc Medicine Inc. | Stock | 0.81% |
| 41 |  | United Therapeutics Corporation | Stock | 0.79% |
| 42 |  | Revolution Medicines, Inc | Stock | 0.74% |
| 43 |  | Ascendis Pharma AS | Stock | 0.73% |
| 44 |  | Dyne Therapeutics Inc | Stock | 0.73% |
| 45 |  | Penumbra, Inc | Stock | 0.71% |
| 46 |  | Axsome Therapeutics, Inc | Stock | 0.69% |
| 47 | L LSE:CTEC | ConvaTec Group PLC | Stock | 0.60% |
| 48 |  | Veeva Systems Inc | Stock | 0.57% |
| 49 |  | Viridian Therapeutics Inc | Stock | 0.56% |
| 50 |  | Cigna Corporation | Stock | 0.56% |